Search for: "Merial, Ltd. v. Cipla, Ltd." Results 1 - 14 of 14
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Merial Ltd. v. Cipla, Ltd.: Federal Circuit Strikes a Blow Against Jurisdictional Gamesmanship by Foreign Companies in IP Disputes
2 Jun 2012, 12:50 pm
   In Merial Ltd. v. [read post]
Trade Secret Litigator Blog - http://www.hahnloeser.com/tradesecretlitigator/
Merial v. Cipla: Finding Jurisdiction Over Foreign Patent Infringers
5 Jun 2012, 10:47 am by Ralph A. Dengler
In Merial Ltd. v. [read post]
IP Law Alert - http://www.iplawalert.com
Federal Circuit Rejects Extraterritoriality Limitation for Certain Patent Claims
4 Jun 2012, 3:00 am by Louis M. Solomon
CIPLA Ltd., et al., Nos. 2011-1471, 1472 (Fed. [read post]
One World International Practice Blog - http://blog.internationalpractice.org/
Federal Circuit Softly Splits with Seventh, Ruling that a Defendant Cannot Consent to a Jurisdiction To Preclude Application of Fed. R. Civ. P. 4(k)(2)
31 May 2012, 9:00 pm by Louis M. Solomon
Merial Limited, BASF Agro B.V. v. [read post]
One World International Practice Blog - http://blog.internationalpractice.org/
Pharma & Biotech Global Week in Review 18 August 2010 from IP Think Tank
18 Aug 2010, 12:19 am by Kelly
Merial Ltd. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
ANDA filing creates Nationwide Personal Jurisdiction
18 Mar 2016, 8:10 am by Dennis Crouch
See Merial Ltd. v. [read post]
Patently-O - http://patentlyo.com/patent
Pharma & Biotech Global Week in Review 22 September 2010 from IP Think Tank
21 Sep 2010, 7:47 pm by Kelly
: AMP et al v USPTO et al; Intervet v Merial (ipeg) US: OGD has put the brakes on ANDA supplement reviews; Will it help push generic drug user fees along? [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 11 August 2010 from IP Think Tank
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Futurewei v. Acacia Research: First-to-File Forum Rule Determines Fate of Same Co-Pending Cases Filed One Day Apart
4 Dec 2013, 7:06 am
Merial Ltd. v. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
District Court Determines No Personal Jurisdiction Exists Under Rules (4)(k)(1) and (4)(k)(2) of the Federal Rules of Civil Procedure Where Plaintiff Could Show Only a Single Infringing Unit Was Sold in the State and Defendant’s Website and Other Activities Were Not Directed at Residents of the State
8 May 2020, 11:00 am by Stan Gibson and Julia Consoli-Tiensvold
”[1] Merial Ltd. v. [read post]
Patent Lawyer Blog - http://patentlaw.jmbm.com/
U.S. Court of Appeals for the Federal Circuit, Communications Test Design, Inc. v. Contec, LLC, Docket No. 2019-1672
25 Mar 2020, 3:00 pm
” Merial Ltd. v. [read post]
Frederic Borel - http://fredericborel.blogspot.ch/
Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Apple says Judge Koh can't dissolve Galaxy Tab 10.1 preliminary injunction while it's on appeal
10 Sep 2012, 10:08 pm by Florian Mueller
See Merial Ltd. v. [read post]
FOSS Patents - http://www.fosspatents.com